Items where authors include "Porter, K.E."

Article

Myers, C.G., Viswambharan, H. orcid.org/0000-0002-7616-5026, Haywood, N.J. et al. (15 more authors) (2024) Small molecule modulation of insulin receptor-insulin like growth factor-1 receptor heterodimers in human endothelial cells. Molecular and Cellular Endocrinology, 594. 112387. ISSN 0303-7207

Trevelyan, C.J., MacCannell, A.D.V., Stewart, L. et al. (11 more authors) (2024) MiR-214–3p regulates Piezo1, lysyl oxidases and mitochondrial function in human cardiac fibroblasts. Matrix Biology, 132. pp. 34-46. ISSN 0945-053X

Hussain, A., Asare-Amankwah, Y., Qureshi, S. et al. (8 more authors) (2024) Defining the miRnome of Saphenous Vein Smooth Muscle Cells from Patients with Type 2 Diabetes Mellitus. Diabetology, 5 (2). pp. 178-189. ISSN 2673-4540

Bageghni, S.A., Hemmings, K.E., Yuldasheva, N.Y. et al. (11 more authors) (2019) Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction. JCI Insight, 4 (17). ISSN 2379-3708

Clarke, N.E., Fisher, M.J., Porter, K.E. et al. (2 more authors) (2012) Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling. PLOS One, 7 (4). e34747. ISSN 1932-6203

Conference or Workshop Item

Smith, A.J. orcid.org/0000-0001-7283-5611, de Vasconcelos, E.R., Myers, C. et al. (2 more authors) (2023) A NOVEL PROTEIN SAMPLING METHOD USIN STYRENE MALEIC ACID CAN OBTAIN MARKERS SPECIFIC TO TYPE 2 DIABETES MELLITUS IN A MOUSE DIABETES MODEL. In: ETRS & SPCE-TC 2023 Joint Annual Meeting, 10 Oct 2023, Coimbra, Portugal. (Submitted)